164 related articles for article (PubMed ID: 26717204)
1. Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold.
Distinto S; Meleddu R; Yanez M; Cirilli R; Bianco G; Sanna ML; Arridu A; Cossu P; Cottiglia F; Faggi C; Ortuso F; Alcaro S; Maccioni E
Eur J Med Chem; 2016 Jan; 108():542-552. PubMed ID: 26717204
[TBL] [Abstract][Full Text] [Related]
2. 3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase B.
Maccioni E; Alcaro S; Cirilli R; Vigo S; Cardia MC; Sanna ML; Meleddu R; Yanez M; Costa G; Casu L; Matyus P; Distinto S
J Med Chem; 2011 Sep; 54(18):6394-8. PubMed ID: 21777011
[TBL] [Abstract][Full Text] [Related]
3. Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Tok F; Uğraş Z; Sağlık BN; Özkay Y; Kaplancıklı ZA; Koçyiğit-Kaymakçıoğlu B
Bioorg Chem; 2021 Jul; 112():104917. PubMed ID: 33932769
[TBL] [Abstract][Full Text] [Related]
4. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
Engelbrecht I; Petzer JP; Petzer A
Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942
[TBL] [Abstract][Full Text] [Related]
5. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
[TBL] [Abstract][Full Text] [Related]
7. Synthetic approaches to unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles and their MAO-B inhibitory activity. A review.
Karabelyov V; Kondeva-Burdina M; Angelova VT
Bioorg Med Chem; 2021 Jan; 29():115888. PubMed ID: 33360082
[TBL] [Abstract][Full Text] [Related]
8. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.
Ke S; Li Z; Qian X
Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501
[TBL] [Abstract][Full Text] [Related]
9. 1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B.
Shetnev A; Shlenev R; Efimova J; Ivanovskii S; Tarasov A; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2019 Nov; 29(21):126677. PubMed ID: 31537422
[TBL] [Abstract][Full Text] [Related]
10. Indanones as high-potency reversible inhibitors of monoamine oxidase.
Mostert S; Petzer A; Petzer JP
ChemMedChem; 2015 May; 10(5):862-73. PubMed ID: 25820651
[TBL] [Abstract][Full Text] [Related]
11. Discovery of highly selective and potent monoamine oxidase B inhibitors: Contribution of additional phenyl rings introduced into 2-aryl-1,3,4-oxadiazin-5(6H)-one.
Lee J; Lee Y; Park SJ; Lee J; Kim YS; Suh YG; Lee J
Eur J Med Chem; 2017 Apr; 130():365-378. PubMed ID: 28273563
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
Tripathi RK; Goshain O; Ayyannan SR
ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.
Costas-Lago MC; Besada P; Rodríguez-Enríquez F; Viña D; Vilar S; Uriarte E; Borges F; Terán C
Eur J Med Chem; 2017 Oct; 139():1-11. PubMed ID: 28797881
[TBL] [Abstract][Full Text] [Related]
16. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
Nel MS; Petzer A; Petzer JP; Legoabe LJ
Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of 2-(indolylmethylidene)-2,3-dihydro-1-benzofuran-3-one and 2-(indolyl)-4H-chromen-4-one derivatives as novel monoamine oxidases inhibitors.
Takao K; U S; Kamauchi H; Sugita Y
Bioorg Chem; 2019 Jun; 87():594-600. PubMed ID: 30933784
[TBL] [Abstract][Full Text] [Related]
19. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors.
Di Pietro O; Alencar N; Esteban G; Viayna E; Szałaj N; Vázquez J; Juárez-Jiménez J; Sola I; Pérez B; Solé M; Unzeta M; Muñoz-Torrero D; Luque FJ
Bioorg Med Chem; 2016 Oct; 24(20):4835-4854. PubMed ID: 27396685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
